GH Research
GHRS
17.53
-1.03
-5.55%
GH Research
US · GHRS
#2969 by market cap
Listed 2021
17.53
-1.03
-5.55%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
About GH Research
GH Research Plc is a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients with psychiatric and neurological disorders. The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Sch?nharting, and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.
- Founded
- 2021
- CEO
- Dr. Velichka Valcheva, M.D.,M.Sc.
- Employees
- 73
- Headquarters
- Dublin, Dublin, Ireland
- Fiscal year end
- 12-31
- Website
- ghres.com
Company profile
- Exchange
- US
- Symbol
- GHRS
- Market-cap rank
- #2969
- Listing date
- 2021-06-25
- Market cap
- 1.20B
- Float cap
- 590.64M
- Shares out
- 68.68M
- Float shares
- 33.69M
Sectors & themes
Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.
GH Research discussion 0 comments